A detailed history of Ubs Group Ag transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ubs Group Ag holds 657,347 shares of BMY stock, worth $39.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
657,347
Previous 6,553,359 89.97%
Holding current value
$39.4 Million
Previous $272 Million 87.5%
% of portfolio
0.01%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $42.8 Million - $55.8 Million
1,078,108 Added 16.45%
7,631,467 $395 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $42.8 Million - $56.4 Million
-1,063,674 Reduced 13.96%
6,553,359 $272 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $132 Million - $149 Million
2,745,207 Added 56.35%
7,617,033 $413 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $99.3 Million - $118 Million
-2,048,229 Reduced 29.6%
4,871,826 $250 Million
Q3 2023

Nov 09, 2023

BUY
$57.89 - $64.73 $44.2 Million - $49.4 Million
763,736 Added 12.41%
6,920,055 $402 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $10.9 Million - $12.1 Million
170,841 Added 2.85%
6,156,319 $394 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $55.1 Million - $62.5 Million
-838,733 Reduced 12.29%
5,985,478 $415 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $93.1 Million - $110 Million
1,359,771 Added 24.88%
6,824,211 $491 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $55,700 - $32.9 Million
-428,464 Reduced 7.27%
5,464,440 $388 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $36.9 Million - $40.7 Million
-508,349 Reduced 7.94%
5,892,904 $454 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $67.3 Million - $80.6 Million
-1,093,879 Reduced 14.59%
6,401,253 $467 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $1.23 Million - $1.43 Million
-22,933 Reduced 0.31%
7,495,132 $467 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $20 Million - $23.4 Million
338,260 Added 4.71%
7,518,065 $445 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $75.8 Million - $82.6 Million
1,224,518 Added 20.56%
7,179,805 $480 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $44.2 Million - $49.7 Million
-744,320 Reduced 11.11%
5,955,287 $376 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $36.7 Million - $41.6 Million
635,824 Added 10.49%
6,699,607 $416 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $1.04 Million - $1.15 Million
18,096 Added 0.3%
6,063,783 $366 Million
Q2 2020

Jul 31, 2020

SELL
$54.82 - $64.09 $98.6 Million - $115 Million
-1,799,488 Reduced 22.94%
6,045,687 $355 Million
Q1 2020

May 01, 2020

SELL
$46.4 - $67.43 $108 Million - $156 Million
-2,318,074 Reduced 22.81%
7,845,175 $437 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $174 Million - $227 Million
3,538,088 Added 53.4%
10,163,249 $652 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $38.6 Million - $45.8 Million
-903,304 Reduced 12.0%
6,625,161 $336 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $92.8 Million - $103 Million
2,080,097 Added 38.18%
7,528,465 $341 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $13.5 Million - $16.1 Million
-299,069 Reduced 5.2%
5,448,368 $260 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $116 Million - $150 Million
-2,369,608 Reduced 29.19%
5,747,437 $299 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $17.4 Million - $19.7 Million
316,058 Added 4.05%
8,117,045 $504 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $4.55 Million - $5.67 Million
-89,990 Reduced 1.14%
7,800,987 $432 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $44.7 Million - $51.5 Million
-746,728 Reduced 8.64%
7,890,977 $499 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $64.4 Million - $70.2 Million
1,074,384 Added 14.21%
8,637,705 $529 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $73.5 Million - $84.9 Million
-1,331,405 Reduced 14.97%
7,563,321 $482 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,364,066 Added 18.11%
8,894,726 $496 Million
Q1 2017

Nov 14, 2017

BUY
N/A
7,530,660
7,530,660 $410 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $127B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.